{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:40:29Z","timestamp":1760146829096,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Purpose: Mucormycosis is a rare but emerging and life-threatening infection caused by environmental mold, with a mortality rate of 30\u201370% despite progress in management. A better understanding could improve its management. Method: We conducted a single-center retrospective study of all cases of mucormycosis observed over a decade at the University Hospital of Caen. Results: Between 2014 and 2024, 18 cases of mucormycosis were identified, predominantly in males (n = 11, 65%). Most patients had hematological malignancies (n = 16, 89%). Seven cases were proven, and eleven were classified as probable. The main locations of infection were pulmonary (n = 12, 67%). Since 2021, we have observed an increase in the number of cases, rising from three between 2014 and 2021 to fifteen between 2021 and 2024. Among the 12 patients with pulmonary mucormycosis, all presented with fever except 1, and 67% required oxygen therapy. Chest computed tomography scans revealed an inverse halo sign in one-third of the patients. The first-line treatment consisted of amphotericin B in seventeen patients, posaconazole in one patient, and isavuconazole in one patient. Surgery was performed on seven patients. In cases of cutaneous mucormycosis, all patients underwent surgery, and none died within three months after the diagnosis. Overall, the three-month mortality rate was 39%. Surgical management was associated with a reduction in mortality (0% vs. 64%, p = 0.013). Conclusions: This study highlights the role of PCR for early diagnosis and the key role of surgery in improving clinical outcomes while underscoring the need for better-adapted therapeutic protocols for these rare infections.<\/jats:p>","DOI":"10.3390\/jof10120884","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:04:14Z","timestamp":1734595454000},"page":"884","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology, Clinical, Radiological and Biological Characteristics, and Outcomes of Mucormycosis: A Retrospective Study at a French University Hospital"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8798-6289","authenticated-orcid":false,"given":"Tom","family":"Cartau","sequence":"first","affiliation":[{"name":"Department of Parasitology-Mycology, CHU de CAEN Normandie, 14000 Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-2252","authenticated-orcid":false,"given":"Sylvain","family":"Chantepie","sequence":"additional","affiliation":[{"name":"Institute of Hematology of Basse-Normandie, CHU de CAEN Normandie, 14000 Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lique","family":"Thuillier-Lecouf","sequence":"additional","affiliation":[{"name":"Department of Nephrology, CHU de CAEN Normandie, 14000 Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-2634","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Langlois","sequence":"additional","affiliation":[{"name":"Department of Parasitology-Mycology, CHU de CAEN Normandie, 14000 Caen, France"},{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM) U1311 DYNAMICURE, Universit\u00e9 de Normandie Unicaen, 14000 Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Bonhomme","sequence":"additional","affiliation":[{"name":"Department of Parasitology-Mycology, CHU de CAEN Normandie, 14000 Caen, France"},{"name":"ToxEMAC-ABTE, Universit\u00e9 de Normandie Unicaen, 14000 Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_4","first-page":"101010","article-title":"Epidemiology and prognostic factors of mucormycosis in France (2012\u20132022): A cross-sectional study nested in a prospective surveillance programme","volume":"45","author":"Gouzien","year":"2024","journal-title":"Lancet Reg. Health-Eur."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Allaw, F., Zakhour, J., Nahhal, S.B., Koussa, K., Bitar, E.R., Ghanem, A., Elbejjani, M., and Kanj, S.S. (2023). Mucormycosis: A 14-Year Retrospective Study from a Tertiary Care Center in Lebanon. JoF, 9.","DOI":"10.3390\/jof9080824"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shen, M., Wang, J., Lei, M., and Wang, Z. (2023). The outcome and the risk factors of mucormycosis among patients with hematological diseases: A systematic and meta-analysis. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1268840"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yang, N., Zhang, L., and Feng, S. (2023). Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies. JoF, 9.","DOI":"10.3390\/jof9050592"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"myae030","DOI":"10.1093\/mmy\/myae030","article-title":"Use of the Mucorales qPCR on blood to screen high-risk hematology patients is associated with better survival","volume":"62","author":"Bellanger","year":"2024","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Puerta-Alcalde, P., and Garcia-Vidal, C. (2021). Changing Epidemiology of Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplantation. JoF, 7.","DOI":"10.3390\/jof7100848"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12641","article-title":"Invasive fungal infections in solid organ transplant recipients","volume":"20","author":"Meije","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kim, U., Perzia, B., Kulkarni, P., Rajiniganth, M., Sundar, B., Robin, A.L., Garg Shukla, A., and Maeng, M.M. (2024). COVID-19-associated rhino-orbito-cerebral mucormycosis: A single center prospective study of 264 patients. Orbit, 1\u201310.","DOI":"10.1080\/01676830.2024.2377249"},{"key":"ref_15","first-page":"765","article-title":"Outbreaks of Mucorales and the Species Involved","volume":"185","author":"Walther","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2230.2011.04235.x","article-title":"Pulmonary, rhino-orbital and cutaneous mucormycosis caused by Rhizomucor pusillus in an immunocompromised patient: Cutaneous mucormycosis caused by Rhizomucor pusillus","volume":"37","author":"Hadaschik","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000506272","article-title":"Cutaneous Mucormycosis Resulting from Hematogenous Dissemination of Rhizomucor pusillus in an Immunocompromised Patient","volume":"6","author":"Menzinger","year":"2020","journal-title":"Dermatopathology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e230587","DOI":"10.1136\/bcr-2019-230587","article-title":"Haemophagocytic lymphohistiocytosis with pulmonary mucormycosis: Fatal association","volume":"12","author":"Bhattacharya","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1038\/s41467-018-05820-2","article-title":"Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species","volume":"9","author":"Andrianaki","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: A novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Valkovi\u0107, T., and Dami\u0107, M.S. (2022). Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies. JCM, 11.","DOI":"10.3390\/jcm11154457"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2214\/AJR.17.18792","article-title":"Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time","volume":"210","author":"Hammer","year":"2018","journal-title":"Am. J. Roentgenol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.transproceed.2024.07.005","article-title":"Risk Factors and Outcomes of Mucorales Infection in a Modern Cohort of Solid Organ Transplant, Hematopoietic Cell Transplant, and Chimeric Antigen Receptor T-cell Therapy Recipients","volume":"56","author":"Ogawa","year":"2024","journal-title":"Transplant. Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"ofae426","DOI":"10.1093\/ofid\/ofae426","article-title":"Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in France","volume":"11","author":"Denis","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ofad704","DOI":"10.1093\/ofid\/ofad704","article-title":"A Systematic Review of the Therapeutic Outcome of Mucormycosis","volume":"11","author":"Sigera","year":"2024","journal-title":"Open Forum Infect. Dis."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/12\/884\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:55:20Z","timestamp":1760115320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/10\/12\/884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jof10120884"],"URL":"https:\/\/doi.org\/10.3390\/jof10120884","relation":{},"ISSN":["2309-608X"],"issn-type":[{"type":"electronic","value":"2309-608X"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}